Sandbox MKK: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 24: Line 24:


Metronidazole(250-500mg)
Metronidazole(250-500mg)
|BID
QID
QID
TID to QID (500mg)
|10-14 days  
|10-14 days  
|NO
|NO
|
|-
|-
|Concomitant
|Concomitant
Line 35: Line 40:


Nitroimidazole(500mg)
Nitroimidazole(500mg)
|BID
|10 -14 days
|NO
|-
|Sequential
|PPI(standard dose)+Amoxicillin(1gm)
PPI,Clarithromycin(500mg)+Nitroimidazole(500mg)
|
|
|
|
|
|
|}
|}

Revision as of 15:55, 26 October 2017

TREATMENT

Regimen Drug dose Dosing frequency Duration(days) FDA approval
Clarithromycin triple PPI(standard or double dose

Clarithromycin(500mg)

Amoxicillin(1gm)or Metronidazole(500mg TID)

BID 14 days YES
Bismuth Quadruple PPI(standard dose)

Bismuth subcitrate (120-300mg)or Subsalicylate (300mg)

Tetracyclin(500mg)

Metronidazole(250-500mg)

BID

QID

QID

TID to QID (500mg)

10-14 days NO
Concomitant PPI (standard dose)

Clarithromycin (500mg)

Amoxicillin(1gm)

Nitroimidazole(500mg)

BID 10 -14 days NO
Sequential PPI(standard dose)+Amoxicillin(1gm)

PPI,Clarithromycin(500mg)+Nitroimidazole(500mg)